Project Grants and Cooperative Agreements for Tuberculosis Control Programs

 

To assist State, local health agencies, political subdivisions, and other government entities to conduct TB preventive health service programs to assist in carrying out tuberculosis (TB) control activities designed to prevent transmission of infection and disease. Financial assistance is provided to TB programs to ensure that the program needs for core TB prevention and control activities, human resource development and public health laboratories are met. In addition, objectives include: finding all cases of active tuberculosis and ensuring completion of therapy; finding and screening persons who have had contact with TB patients, evaluating them for TB infection and disease, and ensuring completion of appropriate treatment; and conducting TB surveillance and TB public health laboratory activities that are essential to addressing these priorities. Each of these core activities (completion of therapy, contact investigation, TB surveillance, and TB laboratory activities) is essential to effective TB prevention and control.

Active 93.116 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Fiscal Year 2016 It is estimated that support will continue as provided in fiscal year 2015. Fiscal Year 2016: objectives have been met. Support continued for the 61 tuberculosis (TB) and laboratory cooperative agreements with continued special emphasis on the completion of treatment, contact investigation, and targeted testing of high-risk populations. In addition, funding continued for six awards to support cross-cutting and disease-specific activities, including the prevention and control of HIV, viral hepatitis, STDs, and TB through prevention programs, capacity building for laboratory services, surveillance, human resources and organizational development, and monitoring and evaluation in the US Pacific Islands. Funding was also awarded to expand latent TB investigation testing and treatment to persons within a defined high-risk community in partnership with State and local health departments, community medical providers, and community leader and organizations.
Fiscal Year 2017 To assist with current efforts of state, local and territorial TB Programs to prevent, control, and eventually eliminate tuberculosis (TB) support continued for the 61 jurisdictions with continued special emphasis on the completion of treatment, contact investigation, and targeted testing of high-risk populations. In addition, funding was awarded to six recipients to support cross-cutting and disease-specific activities, including the prevention and control of HIV, viral hepatitis, STDs, and TB through prevention programs, capacity building for laboratory services, surveillance, human resources and organizational development, and monitoring and evaluation in the US Pacific Islands. Funding was also awarded to expand latent TB investigation testing and treatment to persons within a defined high-risk community in partnership with State and local health departments, community medical providers, and community leader and organizations.
Fiscal Year 2018 To assist with current efforts of state, local and territorial TB Programs to prevent, control, and eventually eliminate tuberculosis (TB) direct assistance (including emergency drugs) will be provided and support will continue as in fiscal year 2017.
Fiscal Year 2019 It is estimated that support will continue as provided in fiscal year 2018. National strategy for combating and eliminating tuberculosis, Title 42 Public Health Service Act, Part B, Section 317E(a), 42 USC U.S.C. 247b-6(a) Under Section 317 of the Public Health Service Act, official public health agencies or their bona fide agents of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa. Official public health agencies of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa. Applicants should document the need for assistance, state the objectives of the project, outline the method of operations, describe the evaluation procedures, and provide a budget with justification of funds requested. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, they may contact the CDC Office of Grants Services Technical Information Management Section (OGSTIMS) staff. For this, or further assistance, contact OGSTIMS: Telephone (770) 488-2700, Email: OGSTIMS@cdc.gov. This program is subject to the requirements described in 45 CFR 92. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. The standard application forms as furnished by PHS and required by 45 CFR, Parts 92, must be used for this program. Forms and instructions are available on www.grants.gov. Contact the headquarters or regional location, as appropriate for application deadlines From 120 to 180 days. From 120 to 180 days. From 60 to 90 days. Information on the submission of applications may be obtained from the Grants Management Officer, Office of Grants Services, Centers for Disease Control and Prevention. The standard application forms, as furnished by PHS and required by 45 CFR 92 for State and local governments, must be used for this program. This program is subject to the requirements described in 45 CFR 92. All applications will be reviewed initially for completeness by CDC. Incomplete applications that do not meet the eligibility criteria will not advance. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the notice of funding opportunity (NOFO). Project funds may be used to support both local personnel and individuals in direct assistance (i.e., "in lieu of cash") positions under Section 317 of the Public Health Service Act and to purchase equipment, supplies and services directly related to project activities, particularly directly observed therapy, patient outreach, morbidity surveillance, outreach and program assessment. Project funds may not be used to supplant State or local funds available for tuberculosis control, or to support construction costs or inpatient care. Performance Reports: See notice of funding opportunity (NOFO) for details. Awardees will meet the annual requirement to report on performance measures with the submission of an Annual Performance Report. However, CDC may request an additional report, the Performance Measure Report, in certain instances such as a jurisdiction’s response to a large TB outbreak. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal officials. Financial records, supporting documents, statistical records, and all other records pertinent to an award shall be retained for a period of three years from the date of submission of the final expenditure report or, for awards that are renewed quarterly or annually, from the date of the submission of the quarterly or annual financial report. If any litigation, claim, financial management review, or audit is started before the expiration of the 3-year period, the records shall be retained until all litigation, claims or audit findings involving the records have been resolved and final action taken. Property records must be retained in accordance with 45 CFR 74.53 and HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Project Period: From one to five years. Budget Period: One year. Method of awarding/releasing assistance: Lump. None/Not specified. Division of Tuberculosis Elimination
1600 Clifton Road, MS E-10
Atlanta, GA 30333 US
KAK4@cdc.gov
Phone: 404-639-5259
Fax: 404-639-8604

Lisa Williams
1600 Clifton Road, MS E-07
Atlanta, GA 30333 USA
LRW3@cdc.gov
Phone: 404-639-1877 http://www.cdc.gov/tb 75-0950-0-1-550 (Cooperative Agreements) FY 18$79,486,233.00; FY 19 est $80,863,811.00; FY 20 FY 17$79,830,700.00; FY 16$80,863,811.00; - It should be noted that for PS13-1304, RTMCCs, the funding in TAGGS is being reported under 93.116 when the NOFO itself shows 93.947. OGS corrected the NoAs by doing deobligation/reobligation for FY13 and FY14; however for FY15 funding is showing under 93.116.(Cooperative Agreements) FY 18$5,618,040.00; FY 19 est $5,618,040.00; FY 20 est $80,498,900.00; - $86,938 to $9,9,317,764 with an average of $1,454,714 Subpart A of 42 CFR 51b is applicable, including all regulations incorporated by reference under Section 51b.105. PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994, is available. Not applicable.